Kalos Health Inc
Analysis
Kalos Health Inc is a registered charity in United States, based in Lockport, NY. It received its IRS tax-exemption ruling in August 2014, 12 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, Kalos Health Inc reported income of $29.9m and spending of $27.4m, spending 92% of its income. Across the 6 years on record, from December 2018 to December 2023, income fell from $71.4m to $29.9m (-58%), an average of -16% a year. The sharpest change came in the year to December 2021, when income dropped by 58%. Over the whole period it spent 97% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Kalos Health Inc sits at the 91st percentile: it is larger than about 91% of them. Against every charity in United States with reported income it ranks in the 98th percentile, and in the 97th percentile within NY. Charities of a similar size with the same main cause include Edgerton Hospital and Health Services Inc ($29.9m), Vail Health Services Foundation ($29.9m) and Adirondack Health Institute Inc ($29.9m).
On its Form 990 for the period ending December 2023, revenue came from program service revenue 98% of the total. Other salaries and wages came to $2.1m. At year end it held assets of $18.9m against liabilities of $10.9m, net assets of $8.1m. It reported 46 employees.
Income and spending
Where the income comes from
- Program services 98%
- Other 1.8%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Edgerton Hospital and Health Services Inc | Edgerton | $29.9m |
| Vail Health Services Foundation | Vail | $29.9m |
| Adirondack Health Institute Inc | Plattsburgh | $29.9m |
| Society of St Vincent de Paul Charitable Pharmacy of North Texas | Dallas | $29.9m |